DEREK ERSTAD to Magnetic Resonance Imaging
This is a "connection" page, showing publications DEREK ERSTAD has written about Magnetic Resonance Imaging.
Connection Strength
0.512
-
Tumor Contrast Enhancement and Whole-Body Elimination of the Manganese-Based Magnetic Resonance Imaging Contrast Agent Mn-PyC3A. Invest Radiol. 2019 11; 54(11):697-703.
Score: 0.277
-
Quantitative, noninvasive MRI characterization of disease progression in a mouse model of non-alcoholic steatohepatitis. Sci Rep. 2021 03 17; 11(1):6105.
Score: 0.076
-
Fibrotic Response to Neoadjuvant Therapy Predicts Survival in Pancreatic Cancer and Is Measurable with Collagen-Targeted Molecular MRI. Clin Cancer Res. 2020 09 15; 26(18):5007-5018.
Score: 0.073
-
Manganese-Based Contrast Agents for Magnetic Resonance Imaging of Liver Tumors: Structure-Activity Relationships and Lead Candidate Evaluation. J Med Chem. 2018 10 11; 61(19):8811-8824.
Score: 0.064
-
Molecular MR Imaging of Renal Fibrogenesis in Mice. J Am Soc Nephrol. 2023 07 01; 34(7):1159-1165.
Score: 0.022